ft.com | UK Follow Moderna shares sink after leaked cancer data missed expectations Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations https://www.ft.com/content/9e59746f-9b63-4adb-b868-14088d638b8a?syn-25a6b1a6=1 ft.com
